Lessons from a Quantitative Analysis of the First Round of CMS Patient Listening Sessions for IRA’s Medicare DPNP Read more about Lessons from a Quantitative Analysis of the First Round of CMS Patient Listening Sessions for IRA’s Medicare DPNP
NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027 Read more about NPC responds to CMS's Information Collection Request on the Negotiation Data Elements and Drug Price Negotiation Process for the Initial Price Applicability Year 2027
NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027 Read more about NPC Submits Comments to CMS on Draft Guidance for the Medicare Drug Price Negotiation Program for 2027
Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program Read more about Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program
New Research Finds Patient Access to Drugs Selected for IRA Is Often High (JAMA Health Forum) Read more about New Research Finds Patient Access to Drugs Selected for IRA Is Often High (JAMA Health Forum)
Development of New Indications for Small Molecule Drugs at Risk under Inflation Reduction Act’s Drug Price Negotiation Program, Study Finds Read more about Development of New Indications for Small Molecule Drugs at Risk under Inflation Reduction Act’s Drug Price Negotiation Program, Study Finds